Gains and losses of DNA are prevalent in cancer and emerge as a consequence of inter-related
processes of replication stress, mitotic errors, spindle multipolarity and breakage–fusion…

Acquired drug resistance to anticancer targeted therapies remains an unsolved clinical
problem. Although many drivers of acquired drug resistance have been identified 1 , 2 , 3 – 4 , …

Mutational signature analysis is commonly performed in cancer genomic studies. Here, we
present SigProfilerExtractor, an automated tool for de novo extraction of mutational signatures…

Acquired drug resistance to even the most effective anti-cancer targeted therapies remains
an unsolved clinical problem. Although many drivers of acquired drug resistance have been …

Epstein–Barr virus (EBV) is an oncogenic herpesvirus associated with several cancers of
lymphocytic and epithelial origin 1 , 2 – 3 . EBV encodes EBNA1, which binds to a cluster of 20 …

Next generation sequencing technologies (NGS) have been critical in characterizing the
genomic landscape and untangling the genetic heterogeneity of human cancer. Since its advent…

… Ammal Abbasi … Ammal Abbasi … Ammal Abbasi is in the Departments of Cellular and
Molecular Medicine and of Bioengineering, University of California San Diego, La Jolla …

Tobacco smoke, alone or combined with alcohol, is the predominant cause of head and
neck cancer (HNC). Here, we further explore how tobacco exposure contributes to cancer …

Background All cancers harbor somatic mutations in their genomes. In principle, mutations
affecting between one and fifty base pairs are generally classified as small mutational events. …

Breast and ovarian cancers harboring homologous recombination deficiencies (HRD) can
benefit from platinum-based chemotherapies and PARP inhibitors. Standard diagnostic tests …